Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 23, 1997

View Archived Issues

Hoechst Marion Roussel's product pipeline in review

Novel progestins described by Gedeon Richter

New compounds from Knoll for CNS disorders

Pfizer describes agents for dopamine system disorders

Acetylcholinesterase inhibitors under development at Astra

Abbott searches for squalene synthase inhibitors as hypolipidemics

New SERMs prepared at Lilly

Axokine use in retinal degeneration covered in new patent

BM-41.0904: a potential new osteoanabolic agent

New levobupivacaine clinical data presented at European congress

Genetronics receives Phase I SBIR grant for heparin delivery

Orapex: new dental company formed in Canada

First launch for Zeneca's Seroquel

Celgene's thalidomide approvable for ENL

Geron, Johns Hopkins collaborate on stem cell research

Octreotide acetate clinical study commences for new indication

Clinical trials begin with topical impotence treatment

Orphan Medical licenses out European rights to Antizol

Columbia Laboratories issued U.S. patent for drug delivery technology

Cardizem Monovial approved for U.S. marketing

Amgen seeks partner for inflammation R&D program

Cytoclonal allowed U.S. patent for PKD treatment

Acute vasodilating effects of KDI-792 in diabetics

NABI introduces new formulation of WinRho SDF

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...